文献速递新生儿儿童消化与营养

早期新生儿维生素A补充与婴儿死亡率:个体 participant 数据荟萃分析

Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials.
PubMed 文献 · Arch Dis Child · 2018-11-13

BACKGROUND: Biannual vitamin A supplementation is a well-established survival tool for preschool children 6 months and older in vitamin A deficient populations but this schedule misses the opportunity to intervene on most young infant deaths.…

要点

  • 总体新生儿维生素A补充对6月龄(RR 0.97;95%CI 0.89-1.06)和12月龄(RR 1.00;95%CI 0.93-1.08)婴儿生存无影响。
  • 南亚试验中补充显著降低6月龄死亡率(RR 0.87;95%CI 0.77-0.98),非洲试验无获益且提示死亡率增加(RR 1.07;95%CI 1.00-1.15)。
  • 母亲维生素A缺乏中重度(血清视黄醇<0.7 µmol/L比例≥10%或夜盲症≥5%)地区补充可降低6月龄死亡率(RR 0.87;95%CI 0.80-0.94)。

核心结论

  • 新生儿维生素A补充在南亚、母亲维生素A缺乏中重度及早期婴儿死亡率高的地区可降低婴儿死亡率,但在非洲及缺乏率低、早期死亡率低的地区无生存获益。

研究设计与样本

  • 1名研究者撤回但允许使用其数据。

主要发现

  • 总体新生儿维生素A补充对6月龄(RR 0.97;95%CI 0.89-1.06)和12月龄(RR 1.00;95%CI 0.93-1.08)婴儿生存无显著影响。
  • 南亚试验中6月龄死亡率显著降低(RR 0.87;95%CI 0.77-0.98)。
  • 母亲维生素A缺乏中重度地区6月龄死亡率显著降低(RR 0.87;95%CI 0.80-0.94)。
  • 早期婴儿死亡率≥30/1000活产地区6月龄死亡率降低(RR 0.91;95%CI 0.85-0.98)。
  • 非洲试验提示婴儿死亡率增加(RR 1.07;95%CI 1.00-1.15)。

关键数值与推荐

  • 维生素A缺乏中重度定义为母亲血清视黄醇<0.7 µmol/L比例≥10%或夜盲症比例≥5%。
  • 早期婴儿死亡率高定义为≥30/1000活产。
  • 婴儿死亡率75%以上发生在生后6月内地区6月龄死亡率RR 0.92(95%CI 0.84-1.01)。
  • 母亲未受教育比例>32%地区6月龄死亡率RR 0.88(95%CI 0.80-0.96)。

临床怎么用

  • 在母亲维生素A缺乏中重度且早期婴儿死亡率高的南亚等地区,可考虑新生儿维生素A补充以降低6月龄死亡率。
  • 在非洲或维生素A缺乏率低、早期婴儿死亡率低的地区,新生儿维生素A补充未见生存获益,不应常规推荐。

局限性

  • 结果基于试验水平亚组分析,存在异质性且部分亚组置信区间较宽。
  • 1名研究者撤回数据但允许使用,可能影响数据完整性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biannual vitamin A supplementation is a well-established survival tool for preschool children 6 months and older in vitamin A deficient populations but this schedule misses the opportunity to intervene on most young infant deaths. Randomised trials of neonatal vitamin A supplementation (NVAS) in the first few days of life to assess its impact on under 6-month mortality in low/middle-income countries have had varying results. METHODS: Investigators of 11 published randomised placebo-controlled NVAS trials (n=163 567 children) reanalysed their data according to an agreed plan and pooled the primary outcomes of mortality from supplementation through 6 and 12 months of age using random effects models and meta-regression. One investigator withdrew but allowed use of the data. FINDINGS: Overall there was no effect of NVAS on infant survival through 6 (risk ratio (RR) 0.97; 95% CI 0.89 to 1.06) or 12 months of age (RR 1.00; 95% CI 0.93 to 1.08) but results varied by study population characteristics.NVAS significantly reduced 6-month mortality among the trials conducted in Southern Asia (RR 0.87; 95% CI 0.77 to 0.98), in contexts with moderate or severe vitamin A deficiency (defined as 10% or higher proportion of women with serum retinol <0.7 µmol/L or 5% or more women with night blindness) (RR 0.87; 95% CI 0.80 to 0.94), early infant mortality was 30 or more per 1000 live births (RR 0.91; 95% CI 0.85 to 0.98), 75% or more of infant mortality occurred in the first 6 months of life (RR 0.92; 95% CI 0.84 to 1.01), or where >32% mothers had no schooling (RR 0.88; 95% CI 0.80 to 0.96). NVAS did not reduce mortality in the first 6 months of life in trials conducted in Africa, in contexts characterised by a low prevalence of vitamin A deficiency, lower rates of infant mortality and where maternal education was more prevalent. There was a suggestion of increased infant mortality in trials conducted in Africa (RR 1.07; 95% CI 1.00 to 1.15).Individual-level characteristics such as sex, birth weight, gestational age and size, age at dosing, parity, time of breast feeding initiation, maternal education and maternal vitamin A supplementation did not modify the impact of NVAS. CONCLUSION: NVAS reduced infant mortality in South Asia, in contexts where the prevalence of maternal vitamin A deficiency is moderate to severe and early infant mortality is high; but it had no beneficial effect on infant survival in Africa, in contexts where the prevalence of maternal vitamin A deficiency is lower, early infant mortality is low.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials. Arch Dis Child. 2018. PMID: 30425075. doi:10.1136/archdischild-2018-315242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。